Recently, Paulis et al., showed that CD44 was involved in a phenomenon known as ‘vasculogenic mimicry’, defined as the ability of some cells to transdifferentiate into cells with endothelial characteristics and constitute vasculogenic networks independent of angiogenesis, which is associated with tumor aggressiveness and poor prognosis. This evidence concerns the gene CD44 and neoplasm.